Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,854    

Indirect Shares

   247,533      
Direct Value   $43,056,670    

Indirect Value

   $21,938,850      
Total Shares   787,387      
Total Value   $64,995,519      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,570 Incyte Corp $887,749 Immunome Inc. $141,437 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,570 Incyte Corp $887,749 Immunome Inc. $141,437
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
* Premium Members only  

Records found :    852         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 27 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-12-15 4 OE $37.46 $224,760 D/D 6,000 309,689 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-12-16 4 OE $37.46 $224,760 D/D 6,000 309,689 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-03-16 4 A $0.00 $0 D/D 44,850 310,341 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-16 4 OE $38.59 $578,850 D/D 15,000 311,106 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-05-10 4 OE $26.49 $225,509 D/D 8,513 312,352 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-04-22 4 OE $26.49 $264,900 D/D 10,000 312,498 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-04-23 4 OE $26.49 $264,900 D/D 10,000 312,498 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-03-15 4 D $78.39 $1,836,364 D/D (23,426) 313,576 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-04-27 4 OE $21.51 $430,200 D/D 20,000 318,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-04-28 4 OE $21.51 $430,200 D/D 20,000 318,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-05-08 4 OE $21.51 $430,200 D/D 20,000 318,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-02-10 4 AS $110.11 $1,651,650 D/D (15,000) 320,324 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-02-13 4 AS $109.15 $654,900 D/D (6,000) 320,324 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-12-13 4 S $106.89 $106,890 D/D (1,000) 320,424 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-01-13 4 AS $112.25 $1,122,500 D/D (10,000) 320,424 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-01-17 4 AS $111.55 $1,115,500 D/D (10,000) 320,424 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-12-02 4 S $103.97 $155,967 D/D (1,500) 321,424 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-10-31 4 S $86.55 $129,825 D/D (1,500) 322,824 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-11-02 4 A $86.12 $8,612 D/D 100 322,924 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-22 4 D $88.05 $1,155,832 D/D (13,127) 323,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-25 4 AS $87.86 $351,440 D/D (4,000) 323,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-13 4 AS $86.98 $4,620,563 D/D (53,125) 323,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-14 4 AS $86.89 $955,814 D/D (11,000) 323,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-17 4 AS $84.39 $3,516,227 D/D (41,666) 323,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-27 4 AS $81.34 $4,880,448 D/D (60,000) 323,368 0 -
  852  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27  28   29   30   31   32   33   34   35      
  Page 27 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us